Oxidopamine

Fos proto-oncogene, AP-1 transcription factor subunit ; Rattus norvegicus







67 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 31704349 c-Fos Expression after Stochastic Vestibular Stimulation and Levodopa in 6-OHDA Hemilesioned Rats. 2020 Jan 1 2
2 30772369 Parkinson's disease and pain: Modulation of nociceptive circuitry in a rat model of nigrostriatal lesion. 2019 May 1
3 31805115 Bilateral Parkinson's disease model rats exhibit hyperalgesia to subcutaneous formalin administration into the vibrissa pad. 2019 3
4 25637312 Neural mechanism underlying hyperalgesic response to orofacial pain in Parkinson's disease model rats. 2015 Jul 1
5 25327342 New ghrelin agonist, HM01 alleviates constipation and L-dopa-delayed gastric emptying in 6-hydroxydopamine rat model of Parkinson's disease. 2014 Dec 1
6 21855627 c-Fos expression after deep brain stimulation of the pedunculopontine tegmental nucleus in the rat 6-hydroxydopamine Parkinson model. 2011 Nov 1
7 19800912 D1 priming enhances both D1- and D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats. 2010 Jan 3
8 20677375 Age-specific effects of 6-hydroxydopamine lesions of the rat medial prefrontal cortex on stress-induced c-fos expression in subcortical areas. 2010 Aug 16 3
9 17848208 Sensory (nociceptive) stimulation evokes Fos expression in the subthalamus of hemiparkinsonian rats. 2008 Apr 3
10 18338798 Impaired activation of celiac ganglion neurons in vivo after damage to their sympathetic nerve terminals. 2008 Jul 2
11 18576208 Patterns of FOS expression in the spinal cord and periaqueductal grey matter of 6OHDA-lesioned rats. 2008 Aug 4
12 18663473 Fos expression following activation of the ventral pallidum in normal rats and in a model of Parkinson's Disease: implications for limbic system and basal ganglia interactions. 2008 Sep 1
13 18792992 Differential expression of Fos and Zif268 in the nigrostriatal system after methamphetamine administration in a rat model of Parkinson's disease. 2008 Dec 4
14 16504219 L-3,4-dihydroxyphenylalanine-induced c-Fos expression in the CNS under inhibition of central aromatic L-amino acid decarboxylase. 2006 Jun 2
15 16706847 L-DOPA-induced dyskinesia in adult rats with a unilateral 6-OHDA lesion of dopamine neurons is paralleled by increased c-fos gene expression in the subthalamic nucleus. 2006 May 4
16 16725125 Repeated l-DOPA treatment increases c-fos and BDNF mRNAs in the subthalamic nucleus in the 6-OHDA rat model of Parkinson's disease. 2006 Jun 20 1
17 17006656 Fos immunoreactivity in some locomotor neural centres of 6OHDA-lesioned rats. 2006 Nov 2
18 15713275 Dopamine manipulation alters immediate-early gene response of striatal parvalbumin interneurons to cortical stimulation. 2005 Feb 21 4
19 15016420 Sympathetic nervous system mediates cold stress-induced suppression of natural killer cytotoxicity in rats. 2004 Mar 18 1
20 15036599 Sympathetic nervous system mediates cold stress-induced suppression of natural killer cytotoxicity in rats. 2004 Feb 26 1
21 12184738 7-Hydroxy-N,N'-di-n-propyl-2-aminotetraline, a preferential dopamine D3 agonist, induces c-fos mRNA expression in the rat cerebellum. 2002 Jul 1
22 12213641 Induced expression of early response genes/oxidative injury in rat pheochromocytoma (PC12) cell line by 6-hydroxydopamine: implication for Parkinson's disease. 2002 Sep 13 2
23 11282380 NMDA glutamate receptor stimulation is required for the expression of D2 dopamine mediated responses in apomorphine primed 6-hydroxydopamine lesioned rats. 2001 Apr 6 1
24 10683409 Acute immediate-early gene response to 6-hydroxydopamine infusions into the medial forebrain bundle. 2000 3
25 10819899 Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists. 2000 Jun 1 3
26 11011010 Enhancement of the acoustic startle response by dopamine agonists after 6-hydroxydopamine lesions of the substantia nigra pars compacta: corresponding changes in c-Fos expression in the caudate-putamen. 2000 Oct 6 1
27 11070194 Effects of repeated methyl levodopa administration on apomorphine sensitivity of rotational behavior and striatal Fos expression of rats with unilateral 6-OHDA lesions. 2000 Nov 1
28 11501038 Relevance between striatal expression of Fos, proenkephalin mRNA, prodynorphin mRNA and rotation induced by l-stepholidine in 6-hydroxydopamine-lesioned rats. 2000 Oct 1
29 10320705 Time dependence and role of N-methyl-D-aspartate glutamate receptors in the priming of D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats. 1999 May 8 2
30 10408602 Effects of intrasubthalamic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydroxydopamine-lesioned rats: an electrophysiological and c-Fos study. 1999 1
31 10579212 Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats. 1999 1
32 9630593 c-fos gene expression is induced in a subpopulation of striatal neurons following a single administration of a dopamine D1-receptor agonist in adult rats lesioned with 6-OHDA as neonates. 1998 Jun 1 1
33 9678640 Methamphetamine-induced Fos expression in the substantia nigra pars reticulata in rats with a unilateral 6-OHDA lesion of the nigrostriatal fibers. 1998 Apr 1
34 9759976 The role of nigrostriatal dopamine in metabotropic glutamate agonist-induced rotation. 1998 Dec 1
35 9795171 Methamphetamine induces fos expression in the striatum and the substantia nigra pars reticulata in a rat model of Parkinson's disease. 1998 Oct 26 1
36 9852594 Amphetamine-induced behavior, dopamine release, and c-fos mRNA expression: modulation by environmental novelty. 1998 Dec 15 1
37 9063681 Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats. 1997 Feb 26 2
38 9178866 Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine-lesioned rats. 1997 Jul 1
39 9195609 Dopamine/glutamate interaction as studied by combining turning behaviour and c-Fos expression. 1997 Jul 2
40 9219861 Adenosine A2A receptor agonists increase Fos-like immunoreactivity in mesolimbic areas. 1997 Jun 6 1
41 9262200 Treadmill running induces striatal Fos expression via NMDA glutamate and dopamine receptors. 1997 Jul 2
42 8714707 Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum. 1996 Feb 6
43 8721156 Time course of striatal changes induced by 6-hydroxydopamine lesion of the nigrostriatal pathway, as studied by combined evaluation of rotational behaviour and striatal Fos expression. 1996 Feb 1
44 8752587 Blockade of A2a adenosine receptors positively modulates turning behaviour and c-Fos expression induced by D1 agonists in dopamine-denervated rats. 1996 Jun 1
45 8813576 Contrasting effects of SM-9018, a potential atypical antipsychotic, and haloperidol on c-fos mRNA expression in the rat striatum. 1996 May 15 1
46 8883820 Effect of MK 801 on priming of D1-dependent contralateral turning and its relationship to c-fos expression in the rat caudate-putamen. 1996 Sep 1
47 9017239 Synergistic interaction between an adenosine antagonist and a D1 dopamine agonist on rotational behavior and striatal c-Fos induction in 6-hydroxydopamine-lesioned rats. 1996 Dec 16 2
48 7477877 Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity. 1995 May 1
49 7477908 Adenosine A2 receptors stimulate c-fos expression in striatal neurons of 6-hydroxydopamine-lesioned rats. 1995 Jul 3
50 7478217 Elevated striatal Fos immunoreactivity following 6-hydroxydopamine lesioning of the rat is mediated by excitatory amino acid transmission. 1995 Jul 14 2